1. Bayer Pharma AG. Xarelto® (rivaroxaban) Summary of Product Characteristics. 2014. http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000944/human_med_001155.jsp . Accessed 28 May 2014.
2. Janssen Pharmaceuticals Inc. Xarelto® (rivaroxaban) Prescribing Information. 2014. http://www.xareltohcp.com/sites/default/files/pdf/xarelto_0.pdf#zoom=100 . Accessed 28 May 2014.
3. Boehringer Ingelheim International GmbH. Pradaxa® (dabigatran etexilate) Summary of Product Characteristics. 2014. http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000829/human_med_000981.jsp . Accessed 28 May 2014.
4. Boehringer Ingelheim Pharmaceuticals Inc. Pradaxa® (dabigatran etexilate) Prescribing Information. 2014. http://bidocs.boehringer-ingelheim.com/BIWebAccess/ViewServlet.ser?docBase=renetnt&folderPath=/Prescribing%20Information/PIs/Pradaxa/Pradaxa.pdf . Accessed 28 May 2014.
5. Bristol–Myers Squibb, Pfizer EEIG. Eliquis® (apixaban) Summary of Product Characteristics. 2014. http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002148/human_med_001449.jsp&mid=WC0b01ac058001d124 . Accessed 28 May 2014.